Cargando…
Cell death-based treatment of glioblastoma
Cancer cells including glioblastoma have typically evolved multiple mechanisms to escape programmed cell death in order to maintain their survival. Defects in cell death mechanisms not only facilitate tumorigenesis but also ensure resistance to current anticancer therapies. This emphasizes that targ...
Autor principal: | Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833770/ https://www.ncbi.nlm.nih.gov/pubmed/29371590 http://dx.doi.org/10.1038/s41419-017-0021-8 |
Ejemplares similares
-
Alternative Cell Death Pathways and Cell Metabolism
por: Fulda, Simone
Publicado: (2013) -
Cell Death Pathways as Therapeutic Targets in Rhabdomyosarcoma
por: Fulda, Simone
Publicado: (2012) -
Smac mimetic-induced upregulation of interferon-β sensitizes glioblastoma to temozolomide-induced cell death
por: Marschall, V, et al.
Publicado: (2015) -
Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells
por: Zielke, Svenja, et al.
Publicado: (2018) -
Cellular Stress Responses: Cell Survival and Cell Death
por: Fulda, Simone, et al.
Publicado: (2010)